Ketorolac + Olopatadine in pharma franchise in Mizoram

Ketorolac + Olopatadine in PCD pharma franchise in Gujarat

Ketorolac + Olopatadine in top pharma company in Kohima

Ketorolac + Olopatadine in pcd pharma supplier in Agra

Ketorolac + Olopatadine in phama franchise company in India
Ketorolac + Olopatadine in phama distributor in Jodhpur

Home/Products /ketorolac-0-point-4-w-v-olopatadine-0-point-1-w-v-eye-drop

Oloplit KT Eye Drops

Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹224/-

Oloplit KT Eye Drops is a combination of Ketorolac (0.4% w/v) and Olopatadine (0.1% w/v), designed for the treatment of eye conditions characterized by inflammation and allergic reactions. This powerful formulation combines two active ingredients: Ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), and Olopatadine, an antihistamine, to provide both anti-inflammatory and anti-allergic effects.

Ketorolac works by inhibiting the action of cyclooxygenase (COX), enzymes responsible for the production of prostaglandins, which are chemicals that cause inflammation and pain in the body. This reduces ocular inflammation, alleviating conditions such as conjunctivitis and post-surgical irritation. Olopatadine, on the other hand, blocks histamine receptors in the eyes, helping to relieve symptoms of eye allergies such as itching, redness, and swelling.

This dual-action combination makes Ketorine OL Eye Drop highly effective in managing both inflammation and allergic reactions in the eyes. It is commonly prescribed to treat allergic conjunctivitis, seasonal allergies, and inflammation following eye surgery or injury.

Read More

About the Product

Oloplit KT Eye Drops is a combination of Ketorolac (0.4% w/v) and Olopatadine (0.1% w/v), designed for the treatment of eye conditions characterized by inflammation and allergic reactions. This powerful formulation combines two active ingredients: Ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), and Olopatadine, an antihistamine, to provide both anti-inflammatory and anti-allergic effects.

Ketorolac works by inhibiting the action of cyclooxygenase (COX), enzymes responsible for the production of prostaglandins, which are chemicals that cause inflammation and pain in the body. This reduces ocular inflammation, alleviating conditions such as conjunctivitis and post-surgical irritation. Olopatadine, on the other hand, blocks histamine receptors in the eyes, helping to relieve symptoms of eye allergies such as itching, redness, and swelling.

This dual-action combination makes Ketorine OL Eye Drop highly effective in managing both inflammation and allergic reactions in the eyes. It is commonly prescribed to treat allergic conjunctivitis, seasonal allergies, and inflammation following eye surgery or injury.

Common side effects include temporary stinging or burning sensations, dryness, or redness of the eye. Less frequently, patients may experience blurred vision, increased tear production, or sensitivity to light.

Ketorine OL Eye Drop is indicated for the treatment of inflammation and allergic conjunctivitis, as well as to relieve post-operative eye inflammation and irritation.

For external use only. Avoid contamination of the tip of the dropper. If eye irritation persists, discontinue use and consult a doctor.

Store in a cool, dry place at a temperature below 25°C. Keep the bottle tightly closed and protect it from light. Do not freeze.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation